Gene Biotherapeutics, Inc.
CRXM · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $386 | $0 | $82 | $49 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $25 | $32 | $19 | $25 |
| Total Curr. Assets | $411 | $33 | $101 | $74 |
| Property Plant & Equip (Net) | $149 | $3 | $61 | $124 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $7 | $0 | $0 | $12 |
| Total NC Assets | $156 | $3 | $61 | $136 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $567 | $35 | $162 | $210 |
| Liabilities | – | – | – | – |
| Payables | $746 | $967 | $1,858 | $1,870 |
| Short-Term Debt | $1,153 | $999 | $1,066 | $1,231 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3,129 | $2,797 | $2,867 | $2,254 |
| Total Curr. Liab. | $5,027 | $4,763 | $5,791 | $5,356 |
| LT Debt | $108 | $122 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $10 |
| Total NC Liab. | $108 | $122 | $0 | $10 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $150 | $0 | $0 | $0 |
| Total Liabilities | $5,135 | $4,885 | $5,791 | $5,366 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $4 | $1 | $1 | $1 |
| Retained Earnings | -$119,430 | -$118,912 | -$119,779 | -$119,344 |
| AOCI | $0 | $600 | $600 | $600 |
| Other Equity | $115,551 | $114,021 | $114,021 | $113,941 |
| Total Equity | -$3,875 | -$4,290 | -$5,157 | -$4,802 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$693 | -$560 | -$472 | -$354 |
| Total Liab. & Tot. Equity | $567 | $35 | $162 | $210 |
| Net Debt | $874 | $1,121 | $984 | $1,182 |